These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33857380)

  • 1. Risk Factors for Intra-Abdominal Infections Caused by Carbapenemase-Producing
    Mora-Guzmán I; Rubio-Perez I; Domingo-Garcia D; Martin-Perez E
    Surg Infect (Larchmt); 2021 Oct; 22(8):864-870. PubMed ID: 33857380
    [No Abstract]   [Full Text] [Related]  

  • 2. Intra-Abdominal Infections by Carbapenemase-Producing
    Mora-Guzmán I; Rubio-Perez I; Domingo-Garcia D; Martin-Perez E
    Surg Infect (Larchmt); 2021 Apr; 22(3):266-273. PubMed ID: 32598237
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
    Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M
    Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.
    Marimuthu K; Ng OT; Cherng BPZ; Fong RKC; Pada SK; De PP; Ooi ST; Smitasin N; Thoon KC; Krishnan PU; Ang MLT; Chan DSG; Kwa ALH; Deepak RN; Chan YK; Chan YFZ; Huan X; Zaw Linn K; Tee NWS; Tan TY; Koh TH; Lin RTP; Hsu LY; Sengupta S; Paterson DL; Perencevich E; Harbarth S; Teo J; Venkatachalam I;
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.
    Nicolas-Chanoine MH; Vigan M; Laouénan C; Robert J;
    Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):383-393. PubMed ID: 30488368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study.
    Segagni Lusignani L; Presterl E; Zatorska B; Van den Nest M; Diab-Elschahawi M
    Antimicrob Resist Infect Control; 2020; 9(1):18. PubMed ID: 31988746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China.
    Liu J; Zhang L; Pan J; Huang M; Li Y; Zhang H; Wang R; Zhao M; Li B; Liu L; Gong Y; Bian J; Li X; Tang Y; Lei M; Chen D
    J Infect Dis; 2020 Mar; 221(Suppl 2):S156-S163. PubMed ID: 32176797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical site infection by carbapenemase-producing Enterobacteriaceae. A challenge for today's surgeons.
    Mora-Guzmán I; Rubio-Perez I; Maqueda González R; Domingo Garcia D; Martín-Pérez E
    Cir Esp (Engl Ed); 2020; 98(6):342-349. PubMed ID: 31980150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and Transmission of Carbapenemase-Producing
    Aung AH; Kanagasabai K; Koh J; Hon PY; Ang B; Lye D; Chen SL; Chow A
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0258420. PubMed ID: 34001509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for the development of infections associated with carbapenemase-producing
    Jimenez A; Fennie K; Munoz-Price LS; Ibrahimou B; Abbo LM; Martinez O; Sposato K; Doi Y; Trepka MJ
    Infect Control Hosp Epidemiol; 2021 Jun; 42(6):763-766. PubMed ID: 33213537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries.
    Villegas MV; Pallares CJ; Escandón-Vargas K; Hernández-Gómez C; Correa A; Álvarez C; Rosso F; Matta L; Luna C; Zurita J; Mejía-Villatoro C; Rodríguez-Noriega E; Seas C; Cortesía M; Guzmán-Suárez A; Guzmán-Blanco M
    PLoS One; 2016; 11(4):e0154092. PubMed ID: 27104910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for colonization by carbapenemase-producing enterobacteria at admission to a Surgical ICU: A retrospective study.
    Maseda E; Salgado P; Anillo V; Ruiz-Carrascoso G; Gómez-Gil R; Martín-Funke C; Gimenez MJ; Granizo JJ; Aguilar L; Gilsanz F
    Enferm Infecc Microbiol Clin; 2017; 35(6):333-337. PubMed ID: 27016135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections.
    Bartoletti M; Tedeschi S; Pascale R; Raumer L; Maraolo AE; Palmiero G; Tumietto F; Cristini F; Ambretti S; Giannella M; Lewis RE; Viale P
    Int J Antimicrob Agents; 2018 Mar; 51(3):516-521. PubMed ID: 29410250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Characteristics of Carbapenemase-Producing Enterobacteriaceae in Three Tertiary-Care Korean University Hospitals between 2017 and 2018.
    Kim SH; Kim GR; Jeong J; Kim S; Shin JH
    Jpn J Infect Dis; 2020 Nov; 73(6):431-436. PubMed ID: 32475870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.
    Yan L; Sun J; Xu X; Huang S
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):155. PubMed ID: 32967718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of carbapenemase-producing Enterobacteriaceae (CPE) carriage: a comparative study of NDM-1 and KPC CPE.
    Lim YJ; Park HY; Lee JY; Kwak SH; Kim MN; Sung H; Kim SH; Choi SH
    Clin Microbiol Infect; 2018 Oct; 24(10):1104.e5-1104.e8. PubMed ID: 29870856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trends (SMART).
    Sheng WH; Badal RE; Hsueh PR;
    Antimicrob Agents Chemother; 2013 Jul; 57(7):2981-8. PubMed ID: 23587958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients.
    Schwartz-Neiderman A; Braun T; Fallach N; Schwartz D; Carmeli Y; Schechner V
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1219-25. PubMed ID: 27452597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active case finding for carbapenemase-producing Enterobacteriaceae in a teaching hospital: prevalence and risk factors for colonization.
    Poole K; George R; Decraene V; Shankar K; Cawthorne J; Savage N; Welfare W; Dodgson A
    J Hosp Infect; 2016 Oct; 94(2):125-9. PubMed ID: 27542962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
    Cunha CB; Kassakian SZ; Chan R; Tenover FC; Ziakas P; Chapin KC; Mermel LA
    Am J Infect Control; 2016 Feb; 44(2):126-30. PubMed ID: 26631643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.